Rituximab-induced B cell depletion in autoimmune diseases : potential effects on T cells
Peripheral B cell depletion strategies have been employed recently in the treatment of systemic autoimmune diseases and the initial clinical results have been encouraging. Although the major target of rituximab-based treatments was to reduce the levels of circulating autoantibodies, additional mecha...
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 127(2008), 3 vom: 30. Juni, Seite 280-5 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2008
|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.) |
| Schlagworte: | Journal Article Review Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Rituximab 4F4X42SYQ6 |
| Online verfügbar |
Volltext |